LifeTech Scientific Corporation (1302.HK)
HKD 1.47
(2.08%)
HKD 1.47
(2.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -970.01 Million CNY | -17.7% |
| 2022 | -824.11 Million CNY | 25.32% |
| 2021 | -1.1 Billion CNY | -40.46% |
| 2020 | -785.7 Million CNY | -1543.67% |
| 2019 | 54.42 Million CNY | 116.56% |
| 2018 | -328.55 Million CNY | 27.3% |
| 2017 | -451.93 Million CNY | -1.51% |
| 2016 | -445.2 Million CNY | -305.2% |
| 2015 | -109.87 Million CNY | 38.22% |
| 2014 | -177.83 Million CNY | -12.27% |
| 2013 | -158.41 Million CNY | 20.17% |
| 2012 | -198.44 Million CNY | -7.24% |
| 2011 | -185.04 Million CNY | -121.7% |
| 2010 | -83.46 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -733.57 Million CNY | 24.37% |
| 2024 Q2 | -733.57 Million CNY | 0.74% |
| 2023 Q4 | -970.01 Million CNY | 0.64% |
| 2023 Q3 | -976.3 Million CNY | -28.33% |
| 2023 Q2 | -760.79 Million CNY | 1.39% |
| 2023 FY | -970.01 Million CNY | -17.7% |
| 2023 Q1 | -771.48 Million CNY | 6.39% |
| 2022 Q2 | -906.74 Million CNY | 0.79% |
| 2022 Q1 | -913.92 Million CNY | 17.19% |
| 2022 FY | -824.11 Million CNY | 25.32% |
| 2022 Q4 | -824.11 Million CNY | 0.61% |
| 2022 Q3 | -829.15 Million CNY | 8.56% |
| 2021 Q2 | -510.8 Million CNY | 1.79% |
| 2021 Q3 | -1.11 Billion CNY | -118.21% |
| 2021 FY | -1.1 Billion CNY | -40.46% |
| 2021 Q1 | -520.13 Million CNY | 33.8% |
| 2021 Q4 | -1.1 Billion CNY | 0.99% |
| 2020 Q1 | 61.11 Million CNY | 12.29% |
| 2020 Q2 | 73.21 Million CNY | 19.81% |
| 2020 Q3 | -792.54 Million CNY | -1182.48% |
| 2020 FY | -785.7 Million CNY | -1543.67% |
| 2020 Q4 | -785.7 Million CNY | 0.86% |
| 2019 Q1 | 48.67 Million CNY | 114.82% |
| 2019 Q2 | 90.78 Million CNY | 86.5% |
| 2019 Q3 | 42.76 Million CNY | -52.9% |
| 2019 Q4 | 54.42 Million CNY | 27.27% |
| 2019 FY | 54.42 Million CNY | 116.56% |
| 2018 Q2 | -211.34 Million CNY | 0.0% |
| 2018 FY | -328.55 Million CNY | 27.3% |
| 2018 Q4 | -328.55 Million CNY | 0.0% |
| 2018 Q3 | -328.55 Million CNY | -55.46% |
| 2018 Q1 | -211.34 Million CNY | 53.24% |
| 2017 Q1 | -392.94 Million CNY | 11.74% |
| 2017 FY | -451.93 Million CNY | -1.51% |
| 2017 Q4 | -451.93 Million CNY | 0.0% |
| 2017 Q3 | -451.93 Million CNY | -15.01% |
| 2017 Q2 | -392.94 Million CNY | 0.0% |
| 2016 Q4 | -445.2 Million CNY | 0.0% |
| 2016 FY | -445.2 Million CNY | -305.2% |
| 2016 Q2 | -59.69 Million CNY | 0.0% |
| 2016 Q3 | -445.2 Million CNY | -645.84% |
| 2016 Q1 | -59.69 Million CNY | 45.67% |
| 2015 Q1 | -176.25 Million CNY | 0.89% |
| 2015 Q4 | -109.87 Million CNY | 0.0% |
| 2015 Q3 | -109.87 Million CNY | 37.66% |
| 2015 FY | -109.87 Million CNY | 38.22% |
| 2015 Q2 | -176.25 Million CNY | 0.0% |
| 2014 FY | -177.83 Million CNY | -12.27% |
| 2014 Q4 | -177.83 Million CNY | 0.0% |
| 2014 Q3 | -177.83 Million CNY | -18.82% |
| 2014 Q2 | -149.66 Million CNY | 0.0% |
| 2014 Q1 | -149.66 Million CNY | 5.52% |
| 2013 Q1 | 202.69 Million CNY | 202.14% |
| 2013 Q4 | -158.41 Million CNY | 0.0% |
| 2013 FY | -158.41 Million CNY | 20.17% |
| 2013 Q2 | -175.84 Million CNY | -186.75% |
| 2012 Q2 | -136.74 Million CNY | 0.0% |
| 2012 FY | -198.44 Million CNY | -7.24% |
| 2012 Q4 | -198.44 Million CNY | 0.0% |
| 2011 FY | -185.04 Million CNY | -121.7% |
| 2011 Q4 | -185.04 Million CNY | 0.0% |
| 2010 FY | -83.46 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Vincent Medical Holdings Limited | -138.39 Million HKD | -600.884% |